請用此 Handle URI 來引用此文件:
http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58311
完整後設資料紀錄
DC 欄位 | 值 | 語言 |
---|---|---|
dc.contributor.advisor | 黃敏銓(Min-Chuan Huang) | |
dc.contributor.author | Chia-Hua Chen | en |
dc.contributor.author | 陳家嬅 | zh_TW |
dc.date.accessioned | 2021-06-16T08:11:01Z | - |
dc.date.available | 2014-10-09 | |
dc.date.copyright | 2014-10-09 | |
dc.date.issued | 2014 | |
dc.date.submitted | 2014-03-04 | |
dc.identifier.citation | 1. Jemal, A., et al. (2011) Global cancer statistics. CA Cancer J Clin, 61, 69-90.
2. Chiappa, A., et al. (2009) The management of colorectal liver metastases: Expanding the role of hepatic resection in the age of multimodal therapy. Crit Rev Oncol Hematol, 72, 65-75. 3. Garden, O.J., et al. (2006) Guidelines for resection of colorectal cancer liver metastases. Gut, 55 Suppl 3, iii1-8. 4. (2013) Treatment by stage of colon cancer. http://www.cancer.org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-treating-by-stage-colon. American Cancer Society. 5. (2013) Targeted therapies for colorectal cancer. http://www.cancer.org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-treating-targeted-therapy. American Cancer Society. 6. Yu, A.L., et al. (2010) Anti-GD2 antibody with GM-CSF, interleukin-2, and isotretinoin for neuroblastoma. N Engl J Med, 363, 1324-34. 7. Varki, A., et al. (2009) Historical Background and Overview. In Varki, A., et al. (eds.), Essentials of Glycobiology, Cold Spring Harbor (NY). 8. Hakomori, S. (2002) Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci U S A, 99, 10231-3. 9. Carpelan-Holmstrom, M., et al. (2002) CEA, CA 19-9 and CA 72-4 improve the diagnostic accuracy in gastrointestinal cancers. Anticancer Res, 22, 2311-6. 10. Stanley, P., et al. (2009) N-Glycans. In Varki, A., et al. (eds.), Essentials of Glycobiology, Cold Spring Harbor (NY). 11. Brockhausen, I., et al. (2009) O-GalNAc Glycans. In Varki, A., et al. (eds.), Essentials of Glycobiology, Cold Spring Harbor (NY). 12. Guo, S., et al. (2001) Galactosylation of N-linked oligosaccharides by human beta-1,4-galactosyltransferases I, II, III, IV, V, and VI expressed in Sf-9 cells. Glycobiology, 11, 813-20. 13. Ohyama, C., et al. (1999) Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells. The EMBO journal, 18, 1516-25. 14. Fukuda, M., et al. (1999) C-type lectins and sialyl Lewis X oligosaccharides. Versatile roles in cell-cell interaction. The Journal of cell biology, 147, 467-70. 15. Grabowski, P., et al. (2000) Expression of SIALYL-Le(x) antigen defined by MAb AM-3 is an independent prognostic marker in colorectal carcinoma patients. Int J Cancer, 88, 281-6. 16. Shimodaira, K., et al. (1997) Carcinoma-associated expression of core 2 beta-1,6-N-acetylglucosaminyltransferase gene in human colorectal cancer: role of O-glycans in tumor progression. Cancer Res, 57, 5201-6. 17. Ichikawa, T., et al. (1999) Expression of N-acetyllactosamine and beta1,4-galactosyltransferase (beta4GalT-I) during adenoma-carcinoma sequence in the human colorectum. J Histochem Cytochem, 47, 1593-602. 18. Demetter, P., et al. (2008) The galectin family and digestive disease. J Pathol, 215, 1-12. 19. Lowe, J.B. (2001) Glycosylation, immunity, and autoimmunity. Cell, 104, 809-12. 20. Ujita, M., et al. (2000) Poly-N-acetyllactosamine extension in N-glycans and core 2- and core 4-branched O-glycans is differentially controlled by i-extension enzyme and different members of the beta 1,4-galactosyltransferase gene family. J Biol Chem, 275, 15868-75. 21. Nishie, T., et al. (2010) Beta4-galactosyltransferase-5 is a lactosylceramide synthase essential for mouse extra-embryonic development. Glycobiology, 20, 1311-22. 22. Tokuda, N., et al. (2013) β4GalT6 is involved in the synthesis of lactosylceramide with less intensity than β4GalT5. Glycobiology. 23. Quentin, E., et al. (1990) A genetic defect in the biosynthesis of dermatan sulfate proteoglycan: galactosyltransferase I deficiency in fibroblasts from a patient with a progeroid syndrome. Proc Natl Acad Sci U S A, 87, 1342-6. 24. Almeida, R., et al. (1997) A family of human beta4-galactosyltransferases. Cloning and expression of two novel UDP-galactose:beta-n-acetylglucosamine beta1, 4-galactosyltransferases, beta4Gal-T2 and beta4Gal-T3. J Biol Chem, 272, 31979-91. 25. Zhao, Y., et al. (2008) Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J, 275, 1939-48. 26. Janik, M.E., et al. (2010) Cell migration-the role of integrin glycosylation. Biochim Biophys Acta, 1800, 545-55. 27. Gu, J., et al. (2004) Beta1,4-N-Acetylglucosaminyltransferase III down-regulates neurite outgrowth induced by costimulation of epidermal growth factor and integrins through the Ras/ERK signaling pathway in PC12 cells. Glycobiology, 14, 177-86. 28. Guo, H.B., et al. (2002) Aberrant N-glycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration. Cancer Res, 62, 6837-45. 29. Lee, S.H., et al. (2009) Core3 O-glycan synthase suppresses tumor formation and metastasis of prostate carcinoma PC3 and LNCaP cells through down-regulation of alpha2beta1 integrin complex. J Biol Chem, 284, 17157-69. 30. Margadant, C., et al. (2011) Mechanisms of integrin activation and trafficking. Curr Opin Cell Biol, 23, 607-14. 31. Harburger, D.S., et al. (2009) Integrin signalling at a glance. J Cell Sci, 122, 159-63. 32. Wong, G.S., et al. (2013) Matricellular proteins: priming the tumour microenvironment for cancer development and metastasis. Br J Cancer, 108, 755-61. 33. Lee, M., et al. (2012) Cleavage of ST6Gal I by radiation-induced BACE1 inhibits golgi-anchored ST6Gal I-mediated sialylation of integrin beta1 and migration in colon cancer cells. Radiat Oncol, 7, 47. 34. Zhao, Y., et al. (2006) Deletion of core fucosylation on alpha3beta1 integrin down-regulates its functions. J Biol Chem, 281, 38343-50. 35. Bellis, S.L. (2004) Variant glycosylation: an underappreciated regulatory mechanism for beta1 integrins. Biochim Biophys Acta, 1663, 52-60. 36. Pinho, S.S., et al. (2009) The role of N-acetylglucosaminyltransferase III and V in the post-transcriptional modifications of E-cadherin. Hum Mol Genet, 18, 2599-608. 37. Yamamoto, E., et al. (2009) N-acetylglucosaminyltransferase V regulates extravillous trophoblast invasion through glycosylation of alpha5beta1 integrin. Endocrinology, 150, 990-9. 38. Zhao, Y., et al. (2006) N-acetylglucosaminyltransferase III antagonizes the effect of N-acetylglucosaminyltransferase V on alpha3beta1 integrin-mediated cell migration. J Biol Chem, 281, 32122-30. 39. Liu, Y.C., et al. (2011) Sialylation and fucosylation of epidermal growth factor receptor suppress its dimerization and activation in lung cancer cells. Proc Natl Acad Sci U S A, 108, 11332-7. 40. Chang, H.H., et al. (2013) beta-1,4-Galactosyltransferase III enhances invasive phenotypes via beta1-integrin and predicts poor prognosis in neuroblastoma. Clin Cancer Res, 19, 1705-16. 41. Amado, M., et al. (1999) Identification and characterization of large galactosyltransferase gene families: galactosyltransferases for all functions. Biochim Biophys Acta, 1473, 35-53. 42. El-Battari, A., et al. (2003) Different glycosyltransferases are differentially processed for secretion, dimerization, and autoglycosylation. Glycobiology, 13, 941-53. 43. Seko, A., et al. (2008) Activation of beta1,3-N-acetylglucosaminyltransferase-2 (beta3Gn-T2) by beta3Gn-T8. Possible involvement of beta3Gn-T8 in increasing poly-N-acetyllactosamine chains in differentiated HL-60 cells. J Biol Chem, 283, 33094-100. 44. Lee, P.L., et al. (2009) Association of beta-1,3-N-acetylglucosaminyltransferase 1 and beta-1,4-galactosyltransferase 1, trans-Golgi enzymes involved in coupled poly-N-acetyllactosamine synthesis. Glycobiology, 19, 655-64. 45. Lagana, A., et al. (2006) Galectin binding to Mgat5-modified N-glycans regulates fibronectin matrix remodeling in tumor cells. Mol Cell Biol, 26, 3181-93. 46. Sanjuan, X., et al. (1997) Differential expression of galectin 3 and galectin 1 in colorectal cancer progression. Gastroenterology, 113, 1906-15. 47. Nakamura, M., et al. (1999) Involvement of galectin-3 expression in colorectal cancer progression and metastasis. Int J Oncol, 15, 143-8. 48. Wu, K.L., et al. (2013) Overexpression of galectin-3 enhances migration of colon cancer cells related to activation of the K-Ras-Raf-Erk1/2 pathway. J Gastroenterol, 48, 350-9. 49. Chen, W.S., et al. (2005) Tumor beta-1,4-galactosyltransferase IV overexpression is closely associated with colorectal cancer metastasis and poor prognosis. Clin Cancer Res, 11, 8615-22. 50. Schultz, M.J., et al. (2012) Regulation of the metastatic cell phenotype by sialylated glycans. Cancer Metastasis Rev, 31, 501-18. 51. Balog, C.I., et al. (2012) N-glycosylation of colorectal cancer tissues: a liquid chromatography and mass spectrometry-based investigation. Mol Cell Proteomics, 11, 571-85. | |
dc.identifier.uri | http://tdr.lib.ntu.edu.tw/jspui/handle/123456789/58311 | - |
dc.description.abstract | 大腸直腸癌(CRC)的病人中常常發生癌細胞轉移,且癌細胞轉移為治療癌症主要的困難所在。在CRC病人中,poly-N-acetyllactosamine相關醣類結構有大量表現上升的情況,且與癌症的形成和轉移有關。B4GALT3是一個調控poly-N-acetyllactosamine製造的酵素,因此我們研究其在CRC中的表現。我們發現B4GALT3的表現與病人的癌組織不良分化(P < 0.001)、癌症末期(P = 0.0052)、區域性淋巴結轉移(P = 0.0018)及遠端轉移(P = 0.0463)呈現負相關。過度表現B4GALT3在CRC細胞株中可以抑制細胞遷移、細胞入侵及附著,而減弱B4GALT3在細胞中的表現量則會增進細胞惡性之行為。加入可以抑制β1 integrin活化的抗體可以反轉B4GALT3所造成細胞入侵的增加。 B4GALT3的表現可以改變β1 integrin上N-glycan的醣化,可能是改變poly-N-acetyllactosamine的表現。此外,減弱B4GALT3在細胞中的表現量則會造成更多β1 integrin及其下游的訊息傳遞的活化,另一方面大量表現B4GALT3則會抑制活化的β1 integrin表現及其下的訊息傳遞。我們的結果說明B4GALT3與CRC的轉移呈現負相關,且經由抑制β1 integrin的活化來減低細胞的入侵能力。 | zh_TW |
dc.description.abstract | Metastasis often occurs in colorectal cancer (CRC) patients and is the main difficulty in cancer treatment. The upregulation of poly-N-acetyllactosamine related glycosylation is found in CRC patients and is associated with progression and metastasis in cancer. B4GALT3 is an enzyme responsible for poly-N-acetyllactosamine synthesis, and therefore we investigated its expression in CRC patients. We found that B4GALT3 negatively correlated with poorly differentiated histology (P < 0.001), advanced stages (P = 0.0052), regional lymph node metastasis (P = 0.0018), and distant metastasis (P = 0.0463) in CRC patients. B4GALT3 overexpression in CRC cells suppressed cell migration, invasion, and adhesion, while B4GALT3 knockdown enhanced malignant cell phenotypes. The β1 integrin blocking antibody reversed the B4GALT3-mediated increase in cell invasion. B4GALT3 expression altered glycosylation on the N-glycan of β1 integrin probably through changes in poly-N-acetyllactosamine expression. Furthermore, more activated β1 integrin along with the activation of its downstream signaling transduction were found in B4GALT3-knockdown cells, whereas overexpression of B4GALT3 suppressed the expression of active β1 integrin and inhibited its downstream signaling. Our results suggest that B4GALT3 is negatively associated with CRC metastasis and suppresses cell invasiveness through inhibiting activation of β1 integrin. | en |
dc.description.provenance | Made available in DSpace on 2021-06-16T08:11:01Z (GMT). No. of bitstreams: 1 ntu-103-D98446002-1.pdf: 24121341 bytes, checksum: 4eea1c01c1669e59fd8be1e609bf3b6a (MD5) Previous issue date: 2014 | en |
dc.description.tableofcontents | 誌謝………………………………………………………………………. i
中文摘要………………………………………………………………….ii 英文摘要…………………………………………………………………iii Chapter 1. Introduction 7 1.1. Colorectal Cancer 7 1.2. Protein glycosylation 8 1.3. Poly-N-acetyllactosamine and its relationship with cancers 9 1.4. β-1,4-galactosyltransferases (B4GALTs) 11 1.5. β1 integrin 13 Chapter 2. Specific aims 15 Chapter 3. Materials and Methods 16 3.1. Immunohistochemistry 16 3.2. Cell culture 16 3.3. Plasmid construction 17 3.4. Stable expression of B4GALT3 18 3.5. Knockdown of B4GALT3 expression 19 3.6. Protein deglycosylation assay 19 3.7. Immunofluorescence 20 3.8. Quantitative RT-PCR 20 3.9. MTT assay 21 3.10. Transwell migration assay 21 3.11. Matrigel invasion assay 22 3.12. Cell adhesion assay 22 3.13. Soft agar colony formation assays 23 3.14. Xenograft 24 3.15. Growth factor receptor signaling 24 3.16. Immunoblotting and lectin pull-down assay 25 3.17. Flow cytometry 26 3.18. Statistical Analysis 26 Chapter 4. Results 28 4.1. B4GALT3 expression correlates with clinicopathologic factors in CRC patients 28 4.2. Modulating and charactering B4GALT3 expression in CRC cells 30 4.3. The effects of B4GALT3 on cell growth vary among CRC cell lines 33 4.4. B4GALT3 inhibited FBS-induced phosphorylation of AKT, FAK, and paxillin 35 4.5. Expression of B4GALT3 in CRC cells suppresses cell migration, invasion, and adhesion on ECM 36 4.6. β1 integrin is involved in B4GALT3-mediated suppression of cell invasion through marigel 38 4.7. B4GALT3 modulates glycosylation of β1 integrin 38 4.8. The LEL-recognized structures exist mainly on N-glycan of β1 integrin in CRC cells 40 4.9. B4GALT3 suppresses the activation of β1 integrin and its downstream signaling pathways 41 Chapter 5. Discussion 43 5.1. Changes of β1 integrin glycosylation by B4GALT3 43 5.2. The β1,6GlcNAc branching N-glycans on β1 integrin and cell invasiveness 44 5.3. B4GALT3 may modulate glycosylation on other receptors which may also contribute to cell invasiveness changes 45 5.4. The functions of B4GALT3 on glycosylation 45 5.5. Poly-N-acetyllactosamines and galectins in CRC 47 5.6. Aberrant glycosylation in CRC 48 Chapter 6. Conclusion 50 | |
dc.language.iso | en | |
dc.title | "β-1,4-galactosyltransferase III抑制β1 integrin調控之大腸直腸癌細胞侵入行為且與大腸直腸癌轉移為負相關" | zh_TW |
dc.title | β-1,4-Galactosyltransferase III suppresses β1 integrin mediated invasive phenotypes and negatively correlates with metastasis in colorectal cancer | en |
dc.type | Thesis | |
dc.date.schoolyear | 102-2 | |
dc.description.degree | 博士 | |
dc.contributor.oralexamcommittee | 李心予(Hsinyu Lee),賴逸儒(I-Rue Lai),李明學(Ming-Shyue Lee),沈湯龍(Tang-Long Shen) | |
dc.subject.keyword | 醣化,轉移,細胞入侵, | zh_TW |
dc.subject.keyword | B4GALT3,β1 integrin,poly-N-acetyllactosamine,glycosylation,metastasis,invasion, | en |
dc.relation.page | 98 | |
dc.rights.note | 有償授權 | |
dc.date.accepted | 2014-03-05 | |
dc.contributor.author-college | 醫學院 | zh_TW |
dc.contributor.author-dept | 解剖學暨細胞生物學研究所 | zh_TW |
顯示於系所單位: | 解剖學暨細胞生物學科所 |
文件中的檔案:
檔案 | 大小 | 格式 | |
---|---|---|---|
ntu-103-1.pdf 目前未授權公開取用 | 23.56 MB | Adobe PDF |
系統中的文件,除了特別指名其著作權條款之外,均受到著作權保護,並且保留所有的權利。